Jay Pandit
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,738 | 1 | 90.1% |
| Food and Beverage | $603.25 | 9 | 9.5% |
| Travel and Lodging | $29.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,738 | 1 | $0 (2022) |
| AstraZeneca AB | $433.72 | 5 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $128.50 | 1 | $0 (2017) |
| PFIZER INC. | $27.11 | 2 | $0 (2019) |
| Abbott Laboratories | $25.15 | 1 | $0 (2023) |
| Novo Nordisk Inc | $17.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.77 | 1 | Novo Nordisk Inc ($17.77) |
| 2023 | $25.15 | 1 | Abbott Laboratories ($25.15) |
| 2022 | $5,738 | 1 | E.R. Squibb & Sons, L.L.C. ($5,738) |
| 2019 | $460.83 | 7 | AstraZeneca AB ($433.72) |
| 2017 | $128.50 | 1 | Actelion Pharmaceuticals US, Inc. ($128.50) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Structural Heart | ||||||
| 07/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $5,737.50 | General |
| Category: Cardiovascular | ||||||
| 12/20/2019 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 08/29/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/26/2019 | AstraZeneca AB | — | Food and Beverage | In-kind items and services | $111.58 | General |
| 03/26/2019 | AstraZeneca AB | — | Food and Beverage | In-kind items and services | $74.83 | General |
| 03/25/2019 | AstraZeneca AB | — | Food and Beverage | In-kind items and services | $143.70 | General |
| 03/25/2019 | AstraZeneca AB | — | Food and Beverage | In-kind items and services | $74.61 | General |
| 03/25/2019 | AstraZeneca AB | — | Travel and Lodging | In-kind items and services | $29.00 | General |
| 04/07/2017 | Actelion Pharmaceuticals US, Inc. | OPSUMIT MACITENTAN (Drug), VELETRI EPOPROSTENOL, VENTAVIS ILOPROST | Food and Beverage | In-kind items and services | $128.50 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 42 | 42 | $17,585 | $4,972 |
| 2021 | 9 | 502 | 591 | $108,193 | $42,105 |
| 2020 | 12 | 907 | 948 | $167,791 | $47,972 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $12,681 | $3,514 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $4,904 | $1,458 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 228 | 317 | $61,498 | $30,751 | 50.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 76 | 76 | $18,130 | $4,199 | 23.2% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2021 | 27 | 27 | $7,529 | $1,674 | 22.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,665 | $1,577 | 33.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $2,948 | $1,337 | 45.4% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 47 | 47 | $3,594 | $835.52 | 23.2% |
| 93350 | Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Facility | 2021 | 14 | 14 | $3,838 | $761.26 | 19.8% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 47 | 47 | $2,439 | $558.04 | 22.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 37 | 37 | $3,552 | $411.99 | 11.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 149 | 182 | $35,308 | $14,602 | 41.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 240 | 245 | $57,272 | $13,847 | 24.2% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2020 | 72 | 72 | $20,232 | $4,527 | 22.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $8,708 | $3,882 | 44.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 45 | 46 | $11,500 | $3,659 | 31.8% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 123 | 124 | $9,323 | $2,112 | 22.6% |
| 93350 | Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Facility | 2020 | 40 | 40 | $10,531 | $1,944 | 18.5% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 123 | 124 | $5,975 | $1,406 | 23.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,925 | $649.40 | 33.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 40 | 40 | $3,840 | $585.98 | 15.3% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Facility | 2020 | 18 | 18 | $1,554 | $416.98 | 26.8% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2020 | 18 | 18 | $1,623 | $341.72 | 21.1% |
About Jay Pandit
Jay Pandit is a Student in an Organized Health Care Education/Training Program healthcare provider based in Geneva, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1700104049.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jay Pandit has received a total of $6,370 in payments from pharmaceutical and medical device companies, with $17.77 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($5,738).
As a Medicare-enrolled provider, Pandit has provided services to 1,451 Medicare beneficiaries, totaling 1,581 services with total Medicare billing of $95,049. Data is available for 3 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Geneva, IL
- Active Since 05/11/2010
- Last Updated 04/18/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1700104049
Products in Payments
- ELIQUIS (Drug) $5,749
- OPSUMIT MACITENTAN (Drug) $128.50
- AMPLATZER AMULET (Device) $25.15
- Rybelsus (Drug) $17.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Geneva
Reihaneh Derafsh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,745
Dr. Emily Gombosi, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $5,850
Dr. Brenda Beck, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $2,196
Nicole Daley
Student in an Organized Health Care Education/Training Program — Payments: $521.05
Christopher Robinson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $428.15
Vattan Sharma, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $311.42